Black patients face higher mortality with melanoma independent of insurance status and severity at diagnosis

Vitiligo most commonly diagnosed in older adults and in Hispanic/Latino and Asian American patients

Study shows safety and tolerability of JAK inhibitors acceptable

Skin lightening agent users have significantly higher composite colorism scores than nonusers

Lymecycline led to earlier reduction in number of lesions and severity of acne; shorter duration of therapy needed with lymecycline

Transplant recipients have increased rates of second cutaneous squamous cell carcinoma, metastasis, death from cutaneous squamous cell carcinoma

Comorbidities associated with vitiligo go beyond just the skin, making it vital that clinicians consider these associated conditions to ensure comprehensive care for their...

Prevalence of atopic dermatitis, asthma, and allergic rhinitis increased compared with heterosexual individuals

Testing significantly less likely when diagnosis made by pediatrician, family practice clinicians

20 percent oxybutynin hydrochloride lotion more effective than placebo for patients aged 12 years and older with primary palmar hyperhidrosis

Higher patient-graded severity for eczema, psoriasis linked to higher symptom expression, greater quality-of-life impairment

Findings especially for flap and graft closures

Cases of true chemo-induced pseudocellulitis resembled infectious cellulitis; did not meet diagnostic criteria for known diagnoses

Two studies show significant improvement in achieving Investigator Global Assessment success and change in inflammatory lesion count from baseline

Half of patients with pain level of 6.5 of 10 expressed preference for OTCs plus opioids when theoretical risk of addiction was low

An overview of new and emerging treatments and research in vitiligo

Everything you need to know this month to stay up to date on the latest research in vitiligo

Treatment of vitiligo can be challenging, but with promising new treatments emerging, the therapeutic options for patients are increasing

Longer median time of flare-free maintenance, greater number of flare-free days, and lower mean number of flares

Approval based on clinical trials, including ALLEGRO Phase 2b/3 trial involving 718 patients with alopecia areata

Spesolimab effects rapid control, with 60 percent of patients achieving GPPGA pustulation subscore of 0 and GPPGA total score of 0 or 1 by...

Patients with ssSSC had lower prevalence of previous or current digital ulcers, puffy fingers compared to those with lcSSc, dcSSc

Preferential activation of JAK1/JAK2-STAT5 pathways observed in eosinophilic cellulitis